Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1967 1
1972 1
1973 2
1974 1
1975 1
1977 1
1978 1
1991 1
1995 1
1996 1
1997 1
1999 1
2000 5
2001 2
2002 3
2003 1
2004 6
2005 6
2006 10
2007 7
2008 3
2009 4
2010 3
2011 12
2012 5
2013 7
2014 9
2015 16
2016 9
2017 28
2018 21
2019 11
2020 10
2021 6
2022 11
2023 6
2024 8
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
In reply.
Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, Berek JS, Manson JE. Parker WH, et al. Among authors: broder ms. Obstet Gynecol. 2013 Aug;122(2 Pt 1):396. doi: 10.1097/AOG.0b013e31829d438c. Obstet Gynecol. 2013. PMID: 23969818 No abstract available.
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.
Babushok DV, DeZern AE, de Castro CM, Rogers ZR, Beenhouwer D, Broder MS, Fanning SR, Gibbs SN, Hanna R, Maciejewski JP, Scott BL, Tantravahi SK, Wlodarski MW, Yermilov I, Patel BJ. Babushok DV, et al. Among authors: broder ms. Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642. Blood Adv. 2024. PMID: 38669341 Free PMC article.
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.
Dingli D, De Castro Iii C, Koprivnikar J, Kulasekararaj A, Maciejewski J, Mulherin B, Panse J, Pullarkat V, Röth A, Shammo J, Terriou L, Weitz I, Yermilov I, Gibbs S, Broder M, Beenhouwer D, Kuter D. Dingli D, et al. Among authors: broder m. Hematology. 2024 Dec;29(1):2329030. doi: 10.1080/16078454.2024.2329030. Epub 2024 Mar 21. Hematology. 2024. PMID: 39665683 Free article.
Nuts and Bolts.
Broder M, Gohsman Z, Steadmon K, Grageda M; Association of Pediatric Program Directors Faculty and Professional Development Task Force. Broder M, et al. Acad Pediatr. 2025 Aug;25(6):102831. doi: 10.1016/j.acap.2025.102831. Epub 2025 Apr 23. Acad Pediatr. 2025. PMID: 40280325 No abstract available.
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America.
Hegele RA, Ahmad Z, Ashraf A, Baldassarra A, Brown AS, Chait A, Freedman SD, Kohn B, Miller M, Patni N, Soffer DE, Wang J, Broder MS, Chang E, Yermilov I, Campos C, Gibbs SN. Hegele RA, et al. Among authors: broder ms. J Clin Lipidol. 2025 Jan-Feb;19(1):83-94. doi: 10.1016/j.jacl.2024.09.008. Epub 2024 Nov 13. J Clin Lipidol. 2025. PMID: 39537503 Free article.
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel.
Kanter J, Ataga KI, Bhasin N, Guarino S, Kutlar A, Lanzkron S, Manwani D, McGann P, Stowell SR, Tubman VN, Yermilov I, Campos C, Broder MS. Kanter J, et al. Among authors: broder ms. Ann Hematol. 2024 Jun;103(6):1909-1917. doi: 10.1007/s00277-024-05736-6. Epub 2024 Apr 20. Ann Hematol. 2024. PMID: 38642304 Review.
212 results